The clinical significance of persistent cancer cells on prostate biopsy after high-dose-rate brachytherapy boost for intermediate-risk prostate cancer

Brachytherapy ◽  
2015 ◽  
Vol 14 (3) ◽  
pp. 309-314 ◽  
Author(s):  
Laura D'Alimonte ◽  
Joelle Helou ◽  
Christopher Sherman ◽  
Andrew Loblaw ◽  
Hans T. Chung ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Dose Rate ◽  
Cancer Cells ◽  
Clinical Significance ◽  
Prostate Biopsy ◽  
High Dose Rate ◽  
High Dose ◽  
Intermediate Risk ◽  
Risk Prostate Cancer ◽  
Brachytherapy Boost

A comparative dosimetric analysis of virtual stereotactic body radiotherapy to high-dose-rate monotherapy for intermediate-risk prostate cancer

Brachytherapy ◽  
2013 ◽  
Vol 12 (5) ◽  
pp. 428-433 ◽  
Author(s):  
Daniel E. Spratt ◽  
Lawrence M. Scala ◽  
Michael Folkert ◽  
Laszlo Voros ◽  
Gil’ad N. Cohen ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Dose Rate ◽  
Stereotactic Body Radiotherapy ◽  
High Dose Rate ◽  
High Dose ◽  
Intermediate Risk ◽  
Risk Prostate Cancer ◽  
Dosimetric Analysis

scholarly journals 171 High-Dose-Rate Brachytherapy as Monotherapy for the Treatment of Intermediate Risk Prostate Cancer: Toxicity Results

2019 ◽  
Vol 139 ◽  
pp. S73
Author(s):  
Yousef Katib ◽  
Cyrus Sani ◽  
Richard Sioufi ◽  
Sergio Faria ◽  
Armen Aprikian ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Dose Rate ◽  
High Dose Rate ◽  
High Dose ◽  
Intermediate Risk ◽  
High Dose Rate Brachytherapy ◽  
Risk Prostate Cancer
Sign in / Sign up

Export Citation Format

Share Document